Ukraine proposes $100 bln US weapons deal for security guarantees - FT
Director Ward Lynne N. of Merit Medical Systems Inc (NASDAQ:MMSI), a $5 billion market cap medical device company, sold 2,433 shares of common stock on August 11, 2025, at a price of $84.8894, for a total value of $206,535. The transaction occurred near the stock’s 52-week low of $81.04, with InvestingPro analysis indicating the stock is currently undervalued.
On the same day, Ward also exercised options to acquire 2,433 shares of Merit Medical Systems at $34.46, for a total value of $83,841.
Following these transactions, Ward directly owns 12,809 shares of Merit Medical Systems Inc.
In other recent news, Merit Medical Systems reported impressive second-quarter 2025 earnings that outperformed market expectations. The company achieved an earnings per share (EPS) of $1.01, significantly surpassing the projected $0.85. Revenue for the quarter reached $382.5 million, exceeding the anticipated $374.18 million. This marks a notable improvement in Merit Medical (TASE:BLWV)’s organic revenue growth, which increased to 6.7% year-over-year, up from 6.0% in the first quarter of 2025. In light of these strong results, Needham has reiterated its Buy rating for Merit Medical, maintaining a price target of $108.00. These developments highlight the company’s robust financial performance and positive outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.